News

‘It’s Synchronicity:’ The Decades-Long Path That Led Philanthropist Carole Ellison to ISB

On a college football Saturday in the 1990s, when ISB co-founder and biotech pioneer Dr. Lee Hood was still at the University of Washington, he delivered a lecture. In the audience was Carole Ellison and her husband, Bill, who were Huskies football season ticket holders. “By happenstance, we signed up to hear him speak,” she recalled. “He was one of four people giving lectures. We chose him. I was so impressed with his enthusiasm and genius and ability to look into the future and see things the rest of us can’t in the health and science fields. I never forgot that experience. His brilliance was remarkable.”

Several years later, Bill passed away from Alzheimer’s disease. Nick Newcombe operated a company that provided elder and chronic care services. “We became friends in the process,” she said of Newcombe, who is now the director of development at ISB.

“It’s synchronicity,” said Ellison, a poet, of the dual paths that came together at ISB.

Newcombe kept in contact with his friend and told her of the research happening at the Seattle non-profit and the emerging field of bioinformatics.

“What an opportunity,” said Ellison, who last week was celebrated at an ISB ceremony for creating and funding the K. Carole Ellison Fellows in Bioinformatics.

“This is monumental for fundraising at ISB,” said Newcombe. “This is the first time in our history that we have had a fellowship 100 percent funded by a philanthropist, and this is the latest way in which Carole has made a significant impact on the science of ISB.”

‘Exciting to be part of their lives’

The recently unveiled fellows program funds two young scientists researching bioinformatics.

Anat Zimmer, Carole Ellison, Tomasz Wilmanski

Carole Ellison, center, poses with Anat Zimmer, left, and Tomasz Wilmanski.

The inaugural fellows are Anat Zimmer, who Ellison calls “brilliant,” and Tomasz Wilmanski, who she said “is an amazing mind.” “It’s so exciting to be part of their lives and help them along in their careers,” she said.

“I am honored and grateful to be a K. Carole Ellison Fellow in Bioinformatics,” said Zimmer. “It provides me the opportunity to be in the right place at the right time to be part of amazing science. Carole is such an inspiring, kind and warm person, and we connected on a personal level. I feel blessed for that.”

“Receiving the K. Carole Ellison Fellowship is a great opportunity, and allows me to bridge my background in nutrition and biology with various computational approaches used at ISB,” said Wilmanski. “It was also a pleasure to thank Carole in person during last week’s reception, and to meet her close friends and family.

While Ellison is responsible for ISB’s first-ever fully funded fellowship, her support of ISB has been steady for years, and was fueled by Hood’s pioneering work in P4 medicine and 21st century health care.

“The subject of wellness vs. sickness and heading off disease in advance makes much more sense than waiting for disease, putting on Band-Aids and hoping for the best,” said Ellison.

“I see it as leading edge, and it’s fun to be a part of it.”

Recent Articles

  • Co-corresponding author and ISB President Dr. Jim Heath and co-lead author Dr. Yapeng Su.

    COVID-19 Immune Response Study Could Lead to More Effective Treatments

    Findings from the ISB-Swedish COVID-19 Immune Response Study suggest that treatments aimed at arresting the infection at the stage of moderate severity may be most effective. The team studied 139 patients and found that mild COVID-19 is very distinct from the moderate or severe forms of disease, which appear surprisingly similar. 

  • Knatokie Ford and Jim Heath

    Dr. Knatokie Ford Shares STEM Journey, Learnings and Advice in ISB-Town Hall Seattle Livestream

    Dr. Knatokie Ford was the featured speaker of a virtual event hosted by ISB and Town Hall Seattle, and shared many of the experiences that helped pave her way to become a leading voice in STEM policy and advocacy, and identified several ways parents and teachers can encourage kids to become tomorrow’s STEM professionals.

  • View of the responsive recruitment website and electronic consent platform as seen on mobile phone and desktop devices.

    ISB Builds Digital Platform for COVID-19 Research Study – and Beyond

    In a multi-institutional study of a highly infectious disease like COVID-19, paperless consent for study participants is critical. One component of the COVID-19 Immune Response Study is a recruitment website with an IRB-approved and HIPAA-compliant electronic consent platform for enrolling patients.